Gayle et al., 1998 - Google Patents
Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.Gayle et al., 1998
View PDF- Document ID
- 11725201020309635853
- Author
- Gayle R
- Maliszewski C
- Gimpel S
- Schoenborn M
- Caspary R
- Richards C
- Brasel K
- Price V
- Drosopoulos J
- Islam N
- Alyonycheva T
- Broekman M
- Marcus A
- et al.
- Publication year
- Publication venue
- The Journal of clinical investigation
External Links
Snippet
Excessive platelet accumulation and recruitment, leading to vessel occlusion at sites of vascular injury, present major therapeutic challenges in cardiovascular medicine. Endothelial cell CD39, an ecto-enzyme with ADPase and ATPase activities, rapidly …
- 102100009509 ENTPD1 0 title abstract description 69
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Gayle et al. | Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. | |
| US5759542A (en) | Compositions and methods for the delivery of drugs by platelets for the treatment of cardiovascular and other diseases | |
| AU2001247219B2 (en) | Integrin antagonists | |
| US6998469B2 (en) | Platelet membrane glycoprotein VI (GPVI) DNA and protein sequences, and uses thereof | |
| CA2060507C (en) | Factor xa based anticoagulant compositions | |
| DK176140B1 (en) | Bat salivary plasminogen activators | |
| JP2008099695A (en) | P-selectin ligand protein | |
| Marcus et al. | Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases | |
| HU228743B1 (en) | Treatment of alpha-galactosidase a deficiency | |
| JP2004528025A (en) | Modified annexin proteins and methods for preventing thrombosis | |
| AU6411599A (en) | Inhibitors of platelet activation and recruitment | |
| Einarsson et al. | Uptake and degradation of tissue plasminogen activator in rat liver | |
| JP2764264B2 (en) | Fibrinolytic activity enhancer | |
| US7074401B2 (en) | Methods, devices, and compositions for lysis of occlusive blood clots while sparing wound sealing clots | |
| US5837488A (en) | Cloning and production of human von Willebrand Factor GP1b binding domain polypeptides and methods of using same | |
| US6638907B1 (en) | Laminin 8 and methods for its use | |
| US20020002277A1 (en) | Inhibitors of platelet activation and recruitment | |
| JP2006241109A (en) | FUSION PROTEIN CONTAINING ANTIBODY AGAINST HUMAN P SELECTIN AND DSPAalpha1 | |
| AU703180B2 (en) | Recombinant alpha-galactosidase enzyme and cDNA encoding said enzyme | |
| NL8700013A (en) | HYBRID PLASMINOGEN ACTIVATORS WITH IMPROVED THROMBOLYTIC PROPERTIES AND MEDICINAL PRODUCTS CONTAINING THESE PLASMINOGEN ACTIVATORS. | |
| US7264809B1 (en) | Methods of inhibiting platelet activation and recruitment | |
| Valentin et al. | Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high-vs. low-shear rate arterial thrombosis in rabbits | |
| KIMATA et al. | Localization of tissue plasminogen activator on experimental microthrombi in rats. Microautoradiographic observations | |
| JPH04346785A (en) | Chimera plus minorgen activator | |
| EP1803810A1 (en) | Integrin antagonists |